{"id":"https://genegraph.clinicalgenome.org/r/5674f7bc-f27c-4c11-a8a1-df13d4b0346cv1.0","type":"EvidenceStrengthAssertion","dc:description":"CAV3 encodes Caveolin-3, a scaffolding protein present in cardiomyocyte caveolae and may be involved in ion channel regulation. Vatta et al. were the first, using a candidate-gene approach, to identify missense variants in CAV3, including putative de-novo variants (paternity not clearly confirmed), in patients with genotype-negative LQTS (PMID 17060380). Overall, however, there have been few studies published which support this gene-disease association and some of the variants in the literature are now known to be relatively frequent in populations, making them very unlikely to be a rare cause of rare disease. Furthermore, no segregation or case-control data is available. Accordingly, the Working Group classified the level of evidence for association of CAV3 with LQTS as limited.\nNote: All LQTS genes were curated by 3 separate blinded teams. The evidence and scores reached by these 3 teams were reviewed by the LQTS Clinical Domain Expert Panel. For a detailed discussion of this group's work and the separate scores of the 3 teams please see \"Adler et al. An International, Multicentered, Evidence-Based Reappraisal of Genes Reported to Cause Congenital Long QT Syndrome. Circulation 2020;141(6):418-428. doi: 10.1161/CIRCULATIONAHA.119.043132”","dc:isVersionOf":"https://genegraph.clinicalgenome.org/r/5674f7bc-f27c-4c11-a8a1-df13d4b0346c","GCISnapshot":"https://genegraph.clinicalgenome.org/r/74aabddc-3402-46de-ba1e-f66aa273cd9c","calculatedEvidenceStrength":"Limited","contributions":[{"id":"https://genegraph.clinicalgenome.org/r/74aabddc-3402-46de-ba1e-f66aa273cd9c_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10025","date":"2020-12-15T00:28:55.870Z","role":"Approver"},{"id":"https://genegraph.clinicalgenome.org/r/74aabddc-3402-46de-ba1e-f66aa273cd9c_publish_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10025","date":"2020-12-22T02:48:15.503Z","role":"Publisher"}],"evidence":[{"id":"https://genegraph.clinicalgenome.org/r/74aabddc-3402-46de-ba1e-f66aa273cd9c_experimental_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/74aabddc-3402-46de-ba1e-f66aa273cd9c_functional_alteration_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/2ca87f2b-d467-4e64-b24c-c33869fd9572","type":"EvidenceLine","calculatedScore":0.5,"direction":"Inconclusive","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/3a6a4d67-f2b2-4cea-b648-7340eb90f0a2","type":"FunctionalAlteration","dc:description":"Mutated CAV3 lose the inhibitory effect on NOS; the increase of intracellular NOS causes the S-nitrosylation of SCN5A and 2-fold increase of late INa","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23541953","rdfs:label":"increase of late INa peaks"}],"specifiedBy":"GeneValidityNonPatientCellFunctionalAlterationCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/31ec9652-d49e-42d5-b27c-a3445347cbb8","type":"EvidenceLine","dc:description":"The Thr78Met variant is quite common on gnomAD but demonstrated similar effect on INaL as the rare variants. The population studied was SIDS and not LQTS.","calculatedScore":0.5,"direction":"Inconclusive","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/62ad4d65-4768-4aec-9f13-7709569a2ae0","type":"FunctionalAlteration","dc:description":"Increase in INaL","dc:source":"https://pubmed.ncbi.nlm.nih.gov/17275750","rdfs:label":"Patch clamp"}],"specifiedBy":"GeneValidityNonPatientCellFunctionalAlterationCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/db0738c2-8cc9-458c-a5f1-8d748cddec27","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/611bbc19-55b4-471d-b183-3567313e1616","type":"FunctionalAlteration","dc:description":"Augmented INaL","dc:source":"https://pubmed.ncbi.nlm.nih.gov/17060380","rdfs:label":"Patch clamp"}],"specifiedBy":"GeneValidityNonPatientCellFunctionalAlterationCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/27412c8a-a470-4706-8ca5-c0239a857b38","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/fd364b3d-b507-48e9-a46b-c08642b2b9bd","type":"FunctionalAlteration","dc:description":"CAV3 mutations decreased significantly the surface membrane expression of Kir2.1 (about 60% less); this causes a 60% decrease in Kir2.1 current density (Ik1)","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23640888","rdfs:label":"Kir2.1 localization and current density"}],"specifiedBy":"GeneValidityNonPatientCellFunctionalAlterationCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallFunctionalAlterationEvidenceCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/74aabddc-3402-46de-ba1e-f66aa273cd9c_functional_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/7ed79229-eda5-4972-bf25-7a4c67736583","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/fdec57c4-72ff-45ad-87fe-3a363ae8887b","type":"Finding","dc:description":"interaction between Kv11.1 and caveolin-3 was confirmed by coimmunoprecipitation analysis","dc:source":"https://pubmed.ncbi.nlm.nih.gov/24021552","rdfs:label":"coimmunoprecipitation with Kv11.1","demonstrates":{"id":"obo:MI_0915"}}],"specifiedBy":"GeneValidityProteinInteractionCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/a4dca67f-724d-406c-ac17-c7c139fcfc8b","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/b594e21c-0082-4f4e-8abb-71a937652bd0","type":"Finding","dc:description":"Robust evidence associating SCN5A with LQTS","dc:source":"https://pubmed.ncbi.nlm.nih.gov/17060380","rdfs:label":"Immunofluorescence","demonstrates":{"id":"obo:MI_0915"}}],"specifiedBy":"GeneValidityProteinInteractionCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/0540927f-7040-49c0-8dc6-e1ab52d22658","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/a9410b06-5bfb-433b-bd9d-08cc1e9405b8","type":"Finding","dc:description":"Demonstrated in control","dc:source":"https://pubmed.ncbi.nlm.nih.gov/14663034","rdfs:label":"Immunostaining","demonstrates":{"id":"cg:GeneExpressionA"}}],"specifiedBy":"GeneValidityGeneExpressionCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallFunctionalEvidenceCriteria","strengthScore":1.5}],"specifiedBy":"GeneValidityOverallExperimentalEvidenceCriteria","strengthScore":2.5},{"id":"https://genegraph.clinicalgenome.org/r/74aabddc-3402-46de-ba1e-f66aa273cd9c_overall_genetic_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/74aabddc-3402-46de-ba1e-f66aa273cd9c_ad_dn_el","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/99147f17-8bf5-4ff9-aa0e-9d26841a92b8_proband_score_evidence_line","type":"EvidenceLine","dc:description":"No ECG tracings, phenotype does not seem to be very convincing, little family info","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/daaf16db-79ff-4281-9981-177d82ad9952","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/17060380","rdfs:label":"06","ageType":"AgeAtDiagnosis","ageUnit":"Years","ageValue":16,"phenotypeFreeText":"Nonexertional syncope + QTc=480 (no tracings)","previousTesting":true,"previousTestingDescription":"Negative for KCNQ1 (LQT1), KCNH2 (LQT2), SCN5A (LQT3), KCNE1 (LQT5), KCNE2 (LQT6), and KCNJ2 (LQT7 or ATS1)—and targeted analysis of ANK2 (LQT4) and RyR2 (CPVT1)","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/99147f17-8bf5-4ff9-aa0e-9d26841a92b8_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/17060380","allele":{"id":"https://genegraph.clinicalgenome.org/r/94b68ce6-13ec-4d16-8550-81fb2dafc909","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_033337.3(CAV3):c.423C>G (p.Ser141Arg)","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/8291"}},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"No"}}],"specifiedBy":"GeneValidityProbandADDeNovoCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/c67183ef-0e6f-4f3f-9c0c-93d815c709e1_proband_score_evidence_line","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/83d7a84a-5453-416a-887f-6acfedb43c0d","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/17060380","rdfs:label":"05","ageType":"AgeAtDiagnosis","ageUnit":"Years","ageValue":13,"firstTestingMethod":"PCR","phenotypeFreeText":"QT prolongation after b-agonist inhalation","previousTesting":true,"previousTestingDescription":"Negative for KCNQ1 (LQT1), KCNH2 (LQT2), SCN5A (LQT3), KCNE1 (LQT5), KCNE2 (LQT6), and KCNJ2 (LQT7 or ATS1)—and targeted analysis of ANK2 (LQT4) and RyR2 (CPVT1)","secondTestingMethod":"Sanger sequencing","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/c67183ef-0e6f-4f3f-9c0c-93d815c709e1_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/17060380","allele":{"id":"https://genegraph.clinicalgenome.org/r/0c8408d2-6f72-4f9d-bbb5-b3077a4099d4","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_033337.3(CAV3):c.290T>G (p.Phe97Cys)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA119452"}},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"No"}}],"specifiedBy":"GeneValidityProbandADDeNovoCriteria","strengthScore":2}],"specifiedBy":"GeneValidityOverallAutosomalDominantDeNovoVariantEvidenceCriteria","strengthScore":3.5},{"id":"https://genegraph.clinicalgenome.org/r/74aabddc-3402-46de-ba1e-f66aa273cd9c_ad_other_el","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/ebcb0c1c-3299-44a4-8889-d92f6b22b213_proband_score_evidence_line","type":"EvidenceLine","dc:description":"the proband's phenotype seems to be due to the KCNH2 variant","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/cd2f48cb-b403-4cb9-81df-361e00ed63f1","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/24021552","rdfs:label":"Proband family with variants in two LQTS genes","detectionMethod":"direct sequencing with primers flanking the coding region","firstTestingMethod":"Sanger sequencing","phenotypes":"obo:HP_0001657","previousTesting":true,"previousTestingDescription":"KCNE1, KCNQ1, KCNE2, SCN5A, KCNH2","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/ebcb0c1c-3299-44a4-8889-d92f6b22b213_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/24021552","allele":[{"id":"https://genegraph.clinicalgenome.org/r/faa895ff-b406-4763-800b-69ed60f03553","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000238.4(KCNH2):c.1199T>A (p.Ile400Asn)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA004263"}},{"id":"https://genegraph.clinicalgenome.org/r/c5c5d67e-ebfe-4a29-a676-690aa3309d1d","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_033337.3(CAV3):c.233C>T (p.Thr78Met)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA119455"}}],"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"}}}],"specifiedBy":"GeneValidityProbandADNonNullCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/ad7b4c4c-19bb-43ba-8005-225898f1f6b9_proband_score_evidence_line","type":"EvidenceLine","dc:description":"No evidence of variant's impact on function. Little phenotype data.","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/d97b98fb-6278-4d19-b5dd-c1bf355686b5","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/26132555","rdfs:label":"1","firstTestingMethod":"Exome sequencing","phenotypeFreeText":"QTc 466 ms","phenotypes":"obo:HP_0005184","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/ad7b4c4c-19bb-43ba-8005-225898f1f6b9_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/26132555","allele":{"id":"https://genegraph.clinicalgenome.org/r/7fc2ccba-5bfe-4d80-89c8-bcfe7f0970b7","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_033337.3(CAV3):c.37A>T (p.Ile13Phe)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA204138"}}}}],"specifiedBy":"GeneValidityProbandADNonNullCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/8dd760ae-f1fc-4af2-b300-6356aecf4dff_proband_score_evidence_line","type":"EvidenceLine","dc:description":"Candidate gene approach, no phenotype details","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/2f5015ce-a874-4528-9d85-10a5739161f2","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/24917393","rdfs:label":"1","firstTestingMethod":"Sanger sequencing","phenotypeFreeText":"Suspected of LQTs, died suddenly","previousTesting":true,"previousTestingDescription":"KCNQ1, KCNH2, SCN5A, KCNE1,\nKCNE2, and KCNJ2) and in ANK2 and RyR2 genes","secondTestingMethod":"Sanger sequencing","sex":"UnknownEthnicity","variant":{"id":"https://genegraph.clinicalgenome.org/r/8dd760ae-f1fc-4af2-b300-6356aecf4dff_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/24917393","allele":{"id":"https://genegraph.clinicalgenome.org/r/02d401e4-f924-4554-8e04-714353dfe567","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_033337.3(CAV3):c.244G>A (p.Val82Ile)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA2236342"}}}}],"specifiedBy":"GeneValidityProbandADNonNullCriteria","strengthScore":0}],"specifiedBy":"GeneValidityOverallAutosomalDominantOtherVariantEvidenceCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/74aabddc-3402-46de-ba1e-f66aa273cd9c_seg_el","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/bbfb8736-d147-462a-9b40-ae65fd205f1f_proband_segregation","type":"FamilyCosegregation","dc:description":"too many inconsistent segregation; the presence of long QT seems to be related to the KCNH2 variant","dc:source":"https://pubmed.ncbi.nlm.nih.gov/24021552","rdfs:label":"family with variants in two LQTS genes","estimatedLodScore":0.9,"family":{"id":"https://genegraph.clinicalgenome.org/r/bbfb8736-d147-462a-9b40-ae65fd205f1f","type":"Family","rdfs:label":"family with variants in two LQTS genes","member":{"id":"https://genegraph.clinicalgenome.org/r/cd2f48cb-b403-4cb9-81df-361e00ed63f1"}},"meetsInclusionCriteria":false,"phenotypePositiveAllelePositive":4,"phenotypes":"obo:HP_0001657","proband":{"id":"https://genegraph.clinicalgenome.org/r/cd2f48cb-b403-4cb9-81df-361e00ed63f1"}}],"specifiedBy":"GeneValiditySegregationEvidenceCriteria","strengthScore":0}],"specifiedBy":"GeneValidityOverallGeneticEvidenceCriteria","strengthScore":3.5}],"evidenceStrength":"Limited","sequence":1619,"specifiedBy":"GeneValidityCriteria8","strengthScore":6,"subject":{"id":"https://genegraph.clinicalgenome.org/r/skMN4zDtdYY","type":"GeneValidityProposition","disease":"obo:MONDO_0002442","gene":"hgnc:1529","modeOfInheritance":"obo:HP_0000006"},"version":"1.0","websiteLegacyID":"https://genegraph.clinicalgenome.org/r/assertion_74aabddc-3402-46de-ba1e-f66aa273cd9c-","@context":{"@vocab":"https://genegraph.clinicalgenome.org/terms/","id":"@id","type":"@type","cg":"https://genegraph.clinicalgenome.org/terms/","dc":"http://purl.org/dc/terms/","obo":"http://purl.obolibrary.org/obo/","hgnc":"https://identifiers.org/hgnc:","rdfs":"http://www.w3.org/2000/01/rdf-schema#","cggv":"https://genegraph.clinicalgenome.org/r/gci/","evidenceStrength":{"@type":"@vocab"},"calculatedEvidenceStrength":{"@type":"@vocab"},"computedEvidenceStrength":{"@type":"@vocab"},"specifiedBy":{"@type":"@vocab"},"evidence":{"@container":"@set"},"disease":{"@type":"@vocab"},"gene":{"@type":"@vocab"},"phenotypes":{"@type":"@id"},"agent":{"@type":"@id"},"role":{"@type":"@vocab"},"modeOfInheritance":{"@type":"@vocab"},"sex":{"@type":"@vocab"},"direction":{"@type":"@vocab"},"ageType":{"@type":"@vocab"},"ageUnit":{"@type":"@vocab"},"dc:source":{"@type":"@id"},"curationReasons":{"@type":"@vocab","@container":"@set"},"GCISnapshot":{"@type":"@id"},"dc:isVersionOf":{"@type":"@id"},"websiteLegacyID":{"@type":"@id"}}}